{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:30:42Z","timestamp":1784302242258,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA013696"],"award-info":[{"award-number":["P30 CA013696"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P30ES009089"],"award-info":[{"award-number":["P30ES009089"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-SUMMIT-108"],"award-info":[{"award-number":["AS-SUMMIT-108"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-TP-108-L09-3"],"award-info":[{"award-number":["AS-TP-108-L09-3"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["107-0210-01-19-01"],"award-info":[{"award-number":["107-0210-01-19-01"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["108-2314-B-001-008"],"award-info":[{"award-number":["108-2314-B-001-008"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jhepr.2021.100410","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T21:06:51Z","timestamp":1637701611000},"page":"100410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV\/HCV infection"],"prefix":"10.1016","volume":"4","author":[{"given":"Hui-Chen","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3706-1259","authenticated-orcid":false,"given":"Wen-Juei","family":"Jeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Hung","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chung","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Nan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwai-I.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2021.100410_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12916-014-0159-5","article-title":"The global burden of liver disease: a challenge for methods and for public health","volume":"12","author":"Byass","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.jhepr.2021.100410_bib2","doi-asserted-by":"crossref","first-page":"45846","DOI":"10.1038\/srep45846","article-title":"International incidence and mortality trends of liver cancer: a global profile","volume":"7","author":"Wong","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2021.100410_bib3","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2021.100410_bib4","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/ijc.31280","article-title":"Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide","volume":"142","author":"Maucort-Boulch","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhepr.2021.100410_bib5","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","article-title":"Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children","volume":"336","author":"Chang","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2021.100410_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/cld.659","article-title":"Impact of hepatitis C virus eradication on hepatocellular carcinoma rates","volume":"10","author":"Zamor","year":"2017","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhepr.2021.100410_bib7","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/hep.27630","article-title":"Significant reduction in end-stage liver diseases burden through the national viral hepatitis therapy program in Taiwan","volume":"61","author":"Chiang","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100410_bib8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/hep.29498","article-title":"Projections of primary liver cancer to 2030 in 30 countries worldwide","volume":"67","author":"Valery","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100410_bib9","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hep.30161","article-title":"Changing trends in etiology-based and ethnicity-based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States","volume":"69","author":"Kim","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100410_bib10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep4.1059","article-title":"Deciphering the epidemiology of hepatocellular carcinoma through the passage of time: a study of 1,401 patients across 3 decades","volume":"1","author":"Goh","year":"2017","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2021.100410_bib11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100410_bib12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/SLA.0000000000000821","article-title":"A\u00a0comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients","volume":"261","author":"Utsunomiya","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2021.100410_bib13","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00535-008-2264-8","article-title":"Etiology of non-B non-C hepatocellular carcinoma in the eastern district of Tokyo","volume":"43","author":"Abe","year":"2008","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jhepr.2021.100410_bib14","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1007\/s10620-019-05938-3","article-title":"Early fibrosis but late tumor stage and worse outcomes in hepatocellular carcinoma patients without hepatitis B or hepatitis C","volume":"65","author":"Hsu","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2021.100410_bib15","doi-asserted-by":"crossref","first-page":"7771","DOI":"10.2147\/CMAR.S257016","article-title":"Development and validation of a prognostic nomogram to predict the long-time prognosis in non-B, non-C hepatocellular carcinoma","volume":"12","author":"Lin","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.jhepr.2021.100410_bib16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100410_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jhepr.2021.100410_bib18","article-title":"Development and validation of a clinical scoring system for predicting risk of HCC in asymptomatic individuals seropositive for anti-HCV antibodies","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2021.100410_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2021.100410_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG clinical guideline: evaluation of abnormal liver Chemistries","volume":"112","author":"Kwo","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2021.100410_bib21","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep4.1182","article-title":"Metabolic risk factors are associated with non-hepatitis B non-hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B","volume":"2","author":"Huang","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2021.100410_bib22","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s41416-018-0007-z","article-title":"Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: the Liver Cancer Pooling Project","volume":"118","author":"Petrick","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhepr.2021.100410_bib23","doi-asserted-by":"crossref","first-page":"753150","DOI":"10.1155\/2013\/753150","article-title":"Trends in prevalence, awareness, treatment, and control of diabetes mellitus in mainland China from 1979 to 2012","volume":"2013","author":"Li","year":"2013","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.jhepr.2021.100410_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019930","article-title":"Body mass index and diabetes in Asia: a cross-sectional pooled analysis of 900,000 individuals in the Asia cohort consortium","volume":"6","author":"Boffetta","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2021.100410_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/ije\/dyt192","article-title":"Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis","volume":"43","author":"Kunutsor","year":"2014","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jhepr.2021.100410_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047687","article-title":"Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients","volume":"7","author":"Hann","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2021.100410_bib27","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/jnci\/djs372","article-title":"Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases","volume":"104","author":"Wen","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jhepr.2021.100410_bib28","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/hep.27610","article-title":"Development of risk scoring system for stratifying population for hepatocellular carcinoma screening","volume":"61","author":"Hung","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100410_bib29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100410_bib30","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1053\/j.gastro.2019.12.053","article-title":"AGA clinical practice update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: expert review","volume":"158","author":"Loomba","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100410_bib31","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/hepr.12647","article-title":"Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: a meta-analysis study","volume":"46","author":"Sun","year":"2016","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhepr.2021.100410_bib32","first-page":"E3","article-title":"Epidemiology of hepatitis B virus infection in the Asia\u2013Pacific region","volume":"15","author":"Chen","year":"2000","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100410_bib33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cgh.2018.04.064","article-title":"Level of hepatitis B (HB) core antibody associates with seroclearance of HBV DNA and HB surface antigen in HB e antigen-seronegative patients","volume":"17","author":"Hu","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100410_bib34","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004311","article-title":"Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: a meta-analysis","volume":"95","author":"Coppola","year":"2016","journal-title":"Medicine (Baltimore)"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921001865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921001865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:26:40Z","timestamp":1762900000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555921001865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2589555921001865"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100410","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV\/HCV infection","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100410"}}